WESTLAKE VILLAGE, Calif., October 29th, 2020 – Southern California-based biodesigns, inc., the leader in non-surgical human interface development and technology, is pleased to announce another patent for their innovative High-Fidelity™ (HiFiTM) Interface technology. This latest patent, Methods for Bone Stabilization, (US10,702,404), complements their interface technology patent portfolio including Methods for Bone Stabilization, (US10,123,888), Methods for Use of Compression Stabilized Prosthetic Socket Interface, (US8,323,353), Method, System, and Tools for Affixing Compression Stabilized Prosthetic Socket Interface, (US8,656,918), Adaptable Socket System, Method and Kit (US9,283,093, US10,369,027, and EP2914221B1), System and Method for Engaging Target with Artificial Limb Equipment (CN106913407B), and Adjustable Pod System, Method and External Member (CN104884005B).
Randall Alley, biodesigns’ CEO, Chief Prosthetist, and Head of User-Interface Technology, has discovered a revolutionary approach for attaching items, equipment, tools and technology non-surgically to the body. The core of the patented and patents-pending HiFi™ Osseostabilizing™ Human Device Interface (HDI) technology is its ability to improve worn device performance and control by syncing the interface more effectively and efficiently to skeletal motion. By surrounding the underlying bone with an alternating array of compression, users experience improved connectivity, a heightened sense of proprioception, and a higher level of device embodiment, whether wearing a prosthesis, exoskeleton, or other wearable technologies.
“When I traveled the world for nearly 15 years fitting complex prosthetic systems, I continually witnessed poor outcomes and high rejection rates caused by the Standard of Care (SOC) sockets being provided. Patients’ biggest complaints were discomfort and feeling disconnected from their prosthesis. It was then I decided to dedicate my career to improving the human device interface by focusing more on interface biomechanics to achieve improved comfort, increased user feedback, enhanced performance, and ultimately greater device acceptance,” stated Alley. “Today, I am pleased to see the HiFi™ interface technology expand into other industries. Our goal is simple – device embodiment so we can be one step closer to seamless human-device integration.”
To make the technology more accessible to patients globally, biodesigns licenses the HiFi™ Prosthetic Interface technology to other Orthotic and Prosthetic (O&P) facilities in the U.S. and abroad, including several NHS (National Health Services) facilities who are interested in improving their outcomes for upper and lower limb prosthetic wearers. Additional programs include a license to their exoskeleton interface technology as well as a license to their recreational consumer interface products, including exolimb™ which is scheduled to launch in 2021.
Southern California-based biodesigns, inc. is a technology-driven facility specializing in the most advanced patient care, research and product development in non-surgical Human Device Interfaces. In prosthetics, it is reestablishing a connection that has been lost; with the military, it is enhancing mission-critical performance and reducing injury; and in consumer wearables it is improving the way individuals interact with tech, tools, and gear. biodesigns’ mission is to create the universal interface standard in Orthotics & Prosthetics (O&P), Exoskeletons, Orthopedics, and consumer wearables. biodesigns’ intellectual property portfolio is managed by Fish IP Law LLP, a premier intellectual property law firm.
For more information visit www.biodesigns.com